These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22735407)

  • 1. Diabetes drug is linked with bladder cancer risk.
    Voelker R
    JAMA; 2012 Jun; 307(24):2577. PubMed ID: 22735407
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes drug may be associated with increase in risk of bladder cancer.
    Stephenson J
    JAMA; 2011 Jul; 306(2):143. PubMed ID: 21750286
    [No Abstract]   [Full Text] [Related]  

  • 3. Pioglitazone and bladder cancer: the pros and cons.
    Panikar V
    J Assoc Physicians India; 2012 Jan; 60():72-3. PubMed ID: 22715550
    [No Abstract]   [Full Text] [Related]  

  • 4. Responding to an FDA warning--geographic variation in the use of rosiglitazone.
    Shah ND; Montori VM; Krumholz HM; Tu K; Alexander GC; Jackevicius CA
    N Engl J Med; 2010 Nov; 363(22):2081-4. PubMed ID: 21083379
    [No Abstract]   [Full Text] [Related]  

  • 5. Revisiting the rosiglitazone story--lessons learned.
    Rosen CJ
    N Engl J Med; 2010 Aug; 363(9):803-6. PubMed ID: 20660395
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetes drug safety update: Avandia and your heart.
    Johns Hopkins Med Lett Health After 50; 2010 Jun; 22(4):1-2, 7. PubMed ID: 20572316
    [No Abstract]   [Full Text] [Related]  

  • 7. The long Avandia endgame.
    Mullard A
    Lancet; 2011 Jul; 378(9786):113. PubMed ID: 21748869
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes.
    Fujimoto K; Hamamoto Y; Honjo S; Kawasaki Y; Mori K; Tatsuoka H; Matsuoka A; Wada Y; Ikeda H; Fujikawa J; Koshiyama H
    Diabetes Res Clin Pract; 2013 Feb; 99(2):e21-3. PubMed ID: 23228390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value equation for rosiglitazone and pioglitazone in older persons.
    Zarowitz BJ
    Geriatr Nurs; 2008; 29(1):9-11. PubMed ID: 18267172
    [No Abstract]   [Full Text] [Related]  

  • 10. The cage in search of a bird.
    Kalra S
    J Assoc Physicians India; 2012 Jan; 60():74-5. PubMed ID: 22715551
    [No Abstract]   [Full Text] [Related]  

  • 11. Comment: analyses using time-dependent pioglitazone usage in Cox models may lead to wrong conclusions about its association with cancer.
    Yang X; Chan JC
    Diabetes Care; 2011 Aug; 34(8):e136; author reply 137. PubMed ID: 21788639
    [No Abstract]   [Full Text] [Related]  

  • 12. Lessons from the Avandia controversy: a new paradigm for the development of drugs to treat type 2 diabetes.
    Misbin RI
    Diabetes Care; 2007 Dec; 30(12):3141-4. PubMed ID: 18042753
    [No Abstract]   [Full Text] [Related]  

  • 13. Panel recommends easing restrictions on rosiglitazone despite concerns about cardiovascular safety.
    Mitka M
    JAMA; 2013 Jul; 310(3):246-7. PubMed ID: 23860970
    [No Abstract]   [Full Text] [Related]  

  • 14. Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries.
    Korhonen P; Heintjes EM; Williams R; Hoti F; Christopher S; Majak M; Kool-Houweling L; Strongman H; Linder M; Dolin P; Bahmanyar S
    BMJ; 2016 Aug; 354():i3903. PubMed ID: 27530399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis confirms raised risk of bladder cancer from pioglitazone.
    Kermode-Scott B
    BMJ; 2012 Jul; 345():e4541. PubMed ID: 22763399
    [No Abstract]   [Full Text] [Related]  

  • 16. The Avandia debate: an unhappy conclusion.
    Bloomgarden Z; Handelsman Y
    J Diabetes; 2010 Dec; 2(4):221-2. PubMed ID: 20923505
    [No Abstract]   [Full Text] [Related]  

  • 17. PROactive study.
    Goldstein MR
    Lancet; 2006 Jan; 367(9504):23; author reply 26-7. PubMed ID: 16399141
    [No Abstract]   [Full Text] [Related]  

  • 18. Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes: a nested case-control study.
    Azoulay L; Schneider-Lindner V; Dell'aniello S; Filion KB; Suissa S
    Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):343-50. PubMed ID: 19998318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone causing urinary bladder cancer? While waiting for the result of the debate, suggestions for physicians.
    Cagiltay E; Tuncel T; Yönem A; Ozdemir G
    Eur J Intern Med; 2013 Mar; 24(2):e21-2. PubMed ID: 23267737
    [No Abstract]   [Full Text] [Related]  

  • 20. The truth about rosiglitazone (avandia).
    Ledbetter C; Laustsen G
    Nurse Pract; 2008 Jun; 33(6):10-1. PubMed ID: 18528195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.